Form 4: Marpai Director Yaron Eitan Boosts Stake with RSU Grant

Marpai, Inc. Director and 10% owner Yaron Eitan acquired 75,000 Class A Common Stock through a Restricted Stock Unit grant.

Summary

• Yaron Eitan, a Director and 10% owner of Marpai, Inc. (MRAI), acquired 75,000 shares of Class A Common Stock.
• The acquisition occurred on August 19, 2025, at a price of $0 per share, indicating a grant of Restricted Stock Units (RSUs).
• Following this transaction, Yaron Eitan directly beneficially owns 1,542,527 shares of Class A Common Stock.
• The RSUs vest over a nine-month period: 25,000 RSUs vested on the three-month anniversary of the grant date, 25,000 RSUs will vest on the six-month anniversary, and the final 25,000 RSUs will vest on the nine-month anniversary.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. An insider, who is also a 10% owner, increasing their stake (even via grant) generally signals confidence in the company's future. It aligns management's interests with shareholders. The $0 price, however, means it's not a direct cash investment, tempering the positive signal slightly compared to an open market purchase.

Positives

• The acquisition of 75,000 shares by a Director and 10% owner signals increased insider alignment with shareholder interests.
• The grant of Restricted Stock Units (RSUs) is a common compensation practice that incentivizes long-term performance and retention of key personnel.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-arranged, compliant trading strategy.

Negatives

• The acquisition was a grant of RSUs at $0 per share, not an open market purchase with personal capital, which would typically signal a stronger conviction in the company's immediate valuation.

Future Outlook

The filing indicates a structured vesting schedule for the granted Restricted Stock Units, with portions vesting at three, six, and nine months from the grant date, aligning the director's future compensation with company performance over this period.

Industry Context

Insider transactions, particularly RSU grants to directors, are a standard component of executive compensation packages across various industries. They are designed to align the interests of management with those of shareholders by tying a portion of compensation to the company's stock performance and ensuring long-term commitment. The use of a 10b5-1 plan is also a common practice for insiders to manage their stock transactions in compliance with SEC regulations.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a director is a common practice in publicly traded companies, comparable to compensation structures seen in technology and healthcare sectors for board members and executives.
• The vesting schedule over nine months is relatively short compared to typical multi-year vesting periods for executive equity grants, which often span three to five years. However, for a director's annual grant, a shorter vesting period can be observed.
• The use of a Rule 10b5-1 plan for this transaction aligns with best practices for insider trading compliance, similar to those adopted by executives at companies like Apple (AAPL) or Microsoft (MSFT) to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders: The increased beneficial ownership by a director and 10% owner can be viewed positively, as it further aligns management's interests with shareholder value creation.
• Employees: The RSU grant is part of a compensation structure that incentivizes long-term commitment and performance, which can indirectly benefit employees through a more stable and focused leadership.

Next Steps

• The remaining 50,000 RSUs will vest in two equal tranches of 25,000 shares on the six-month and nine-month anniversaries of the grant date (February 19, 2026, and May 19, 2026, respectively).

Key Dates

Recommendation

The Form 4 indicates a positive signal of insider alignment through an RSU grant to a director and 10% owner. While this is generally a good sign, a Form 4 alone does not provide sufficient comprehensive financial data to warrant a 'buy' or 'sell' recommendation. It suggests a 'hold' as it reinforces confidence in the existing management's commitment without presenting new fundamental financial performance data.

Keywords

Marpai, MRAI, Yaron Eitan, Insider Transaction, Form 4, Restricted Stock Units, RSU, Director, Ownership, 10b5-1 Plan